Toolkit | June 14, 2017 | Intellectual Property, Legislation
The Bayh-Dole Act benefits the U.S. economy, taxpayers, consumers and patients, but certain activists are trying to undermine the law. Some want to force the government to "march-in" by arbitrarily tying prescription drugs prices in the U.S. to prices set in foreign countries.